tiprankstipranks
Trending News
More News >
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market

Compare Crinetics Pharmaceuticals (CRNX) vs. Competitors

Compare
730 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Crinetics Pharmaceuticals
$45.95
$4.57B
-10.13
-8.99%
10 Buy
1 Hold
0 Sell
Strong Buy
Ligand Pharma
$196.02
$3.78B
94.35
81.63%
7 Buy
0 Hold
0 Sell
Strong Buy
Ultragenyx Pharmaceutical
$22.54
$2.23B
-3.80
-47.16%
17 Buy
1 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$23.94
$3.15B
80.63
-30.37%
9 Buy
5 Hold
0 Sell
Moderate Buy
Kymera Therapeutics
$73.46
$5.72B
-20.43
84.11%
21 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CRNX
Crinetics Pharmaceuticals
45.95
-2.55
-5.26%
LGND
Ligand Pharma
196.02
85.44
77.27%
RARE
Ultragenyx Pharmaceutical
22.54
-21.11
-48.36%
APLS
Apellis Pharmaceuticals
23.94
-9.06
-27.45%
AKRO
KYMR
Kymera Therapeutics
73.46
32.94
81.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts